glp-1 agonists and anesthesia 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f 2025 ADS/ANZCA/GESA/NACOS clinical practice immunity Quantity:Double-Pack ($119)

glp-1 agonists and anesthesia 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f 2025 ADS/ANZCA/GESA/NACOS clinical practice immunity Quantity:Double-Pack ($119)

2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists - PMC

Hydration and consistent dosing are key for sustained appetite management

immunity

Quantity:Double-Pack ($119)

Table 4 lists the agents currently available in the USA and their dosing strategies [19, 38, 55–58]